These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 4995496

  • 21. [Late damage after Rh-erythroblastosis, ABO-erythroblastosis and hyperbilirubinemia in the neonate (author's transl)].
    Weber H, Ströder J.
    Klin Padiatr; 1973 Sep; 185(5):383-99. PubMed ID: 4203603
    [No Abstract] [Full Text] [Related]

  • 22. Prevention of Rh sensitization. Report of a WHO Scientific Group.
    World Health Organ Tech Rep Ser; 1971 Sep; 468():3-36. PubMed ID: 4999558
    [No Abstract] [Full Text] [Related]

  • 23. [Prevention of Rh-immunization with the Rho(D)-immunoglobulin G (RhoGAM)].
    Robertson JG.
    Med Welt; 1970 Nov 14; 46():1991-5. PubMed ID: 4997857
    [No Abstract] [Full Text] [Related]

  • 24. [Screening of irregular antibodies in pregnancy].
    Bolis PF, Zara C.
    Arch Ostet Ginecol; 1972 Nov 14; 77(5):345-51. PubMed ID: 4219579
    [No Abstract] [Full Text] [Related]

  • 25. [Prevention of iso-immunization to blood factors].
    Santana Uribe A, Orduña Castrezana H, Aguirre De Maldonado M, Portillo Silva M.
    Ginecol Obstet Mex; 1968 Dec 14; 24(146):683-7. PubMed ID: 4178492
    [No Abstract] [Full Text] [Related]

  • 26. [IgG-Anti D prevention].
    Speiser P.
    Wien Med Wochenschr; 1971 Sep 04; 121(36):615-7. PubMed ID: 4999917
    [No Abstract] [Full Text] [Related]

  • 27. [An alternative method of treatment for the icteric-anemic form of neonatal iso-immunization to rhesus factor].
    Perepelitsa SA, Kashina NA, Sidorova NL.
    Anesteziol Reanimatol; 2010 Sep 04; (1):60-2. PubMed ID: 20564941
    [Abstract] [Full Text] [Related]

  • 28. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I, Garancsy L, Böröcz I.
    Orv Hetil; 1980 Apr 13; 121(15):875-8. PubMed ID: 6770319
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Advances in treatment of RH negative blood incompatibility of mothers and infants.
    Chinn PC, Mueller JM.
    Ment Retard; 1971 Feb 13; 9(1):12-5. PubMed ID: 4995878
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Prevention of Rh sensitization using immunoglobulin anti-D].
    Stampfli K, de Muralt G.
    Schweiz Med Wochenschr; 1969 Oct 18; 99(42):1519-21. PubMed ID: 4983123
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Rh(D)-immunization in pregnancy].
    Nordhagen R.
    Tidsskr Nor Laegeforen; 1981 May 30; 101(15):934-7. PubMed ID: 6791303
    [No Abstract] [Full Text] [Related]

  • 39. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M.
    Transfusion; 2008 May 30; 48(5):941-52. PubMed ID: 18248570
    [Abstract] [Full Text] [Related]

  • 40. [Morbus hemolyticus neonatorum (erythroblastosis). 2].
    Gallasch E, Karte H, Koziol D, Stein H.
    Med Klin; 1968 Mar 29; 63(13):481-5. PubMed ID: 5727258
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.